Breast Cancer

Top Story

FDA grants priority review to antibody-drug conjugate for HER2-positive metastatic breast cancer

FDA grants priority review to antibody-drug conjugate for HER2-positive metastatic breast cancer
October 17, 2019
Feature

Program seeks to improve rate of genetic testing among patients with breast cancer

October 17, 2019
The University of Kansas Cancer Center has launched a telementoring program designed to improve community oncology providers’ knowledge of genetic testing in…

Roswell Park professor promoted to chief of breast pathology

October 15, 2019
Thaer Khoury, MD , FCAP , has been promoted to chief of breast pathology within the department of pathology and laboratory medicine at Roswell Park…
In the Journals

Systemic sclerosis more than doubles risk for cancer

October 15, 2019
Patients with systemic sclerosis carry a more than twofold increased risk for cancer — particularly lung, early breast and early melanoma — compared with…
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »
Video
Meeting News

VIDEO: ASCO featured multiple exciting breast cancer studies

July 6, 2019
More »
Resource Centers

CME

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the…
More »